JP2024525254A5 - - Google Patents
Info
- Publication number
- JP2024525254A5 JP2024525254A5 JP2024503814A JP2024503814A JP2024525254A5 JP 2024525254 A5 JP2024525254 A5 JP 2024525254A5 JP 2024503814 A JP2024503814 A JP 2024503814A JP 2024503814 A JP2024503814 A JP 2024503814A JP 2024525254 A5 JP2024525254 A5 JP 2024525254A5
- Authority
- JP
- Japan
- Prior art keywords
- urodecine
- solution
- minutes
- crystalline salt
- hemiglutarate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2110403.9A GB202110403D0 (en) | 2021-07-20 | 2021-07-20 | Ulodesine Salt |
| GB2110403.9 | 2021-07-20 | ||
| PCT/EP2022/070369 WO2023001893A1 (en) | 2021-07-20 | 2022-07-20 | Ulodesine salt |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024525254A JP2024525254A (ja) | 2024-07-11 |
| JP2024525254A5 true JP2024525254A5 (https=) | 2025-07-29 |
Family
ID=77443478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024503814A Pending JP2024525254A (ja) | 2021-07-20 | 2022-07-20 | ウロデシン塩 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4373579A1 (https=) |
| JP (1) | JP2024525254A (https=) |
| KR (1) | KR20240038017A (https=) |
| CN (1) | CN117897383A (https=) |
| AU (1) | AU2022314207A1 (https=) |
| CA (1) | CA3226849A1 (https=) |
| GB (1) | GB202110403D0 (https=) |
| MX (1) | MX2024000936A (https=) |
| WO (1) | WO2023001893A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202218782D0 (en) | 2022-12-13 | 2023-01-25 | Mehrling Thomas | Purine nucleoside phosphorylase inhibitor for metabolic syndrome |
| WO2025250900A1 (en) * | 2024-05-30 | 2025-12-04 | Caamtech, Inc. | 4-hydroxy-n,n-diisopropyltryptaminium hydroglutarate |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1539783B1 (en) | 2002-08-21 | 2011-04-13 | Albert Einstein College Of Medicine Of Yeshiva University | Inhibitors of nucleoside phosphorylases and nucleosidases |
| NZ595590A (en) * | 2009-03-24 | 2013-11-29 | Biocryst Pharm Inc | Useful pharmaceutical salts of 7-[(3r,4r)-3-hydroxy-4-hydroxymethyl-pyrrolidin-1-ylmethyl]-3,5-dihydro-pyrrolo[3,2-d]pyrimidin-4-one |
-
2021
- 2021-07-20 GB GBGB2110403.9A patent/GB202110403D0/en not_active Ceased
-
2022
- 2022-07-20 MX MX2024000936A patent/MX2024000936A/es unknown
- 2022-07-20 CN CN202280050721.6A patent/CN117897383A/zh active Pending
- 2022-07-20 CA CA3226849A patent/CA3226849A1/en active Pending
- 2022-07-20 WO PCT/EP2022/070369 patent/WO2023001893A1/en not_active Ceased
- 2022-07-20 JP JP2024503814A patent/JP2024525254A/ja active Pending
- 2022-07-20 EP EP22754840.1A patent/EP4373579A1/en active Pending
- 2022-07-20 AU AU2022314207A patent/AU2022314207A1/en active Pending
- 2022-07-20 KR KR1020247005390A patent/KR20240038017A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019052152A (ja) | トレプロスチニルの塩 | |
| JP2024525254A5 (https=) | ||
| JP4112032B2 (ja) | Ｎ−［３−（３−シアノピラゾロ［１，５−ａ］ピリミジン−７−イル）フェニル］−Ｎ−エチル−アセトアミドの改良された製造方法 | |
| SU988190A3 (ru) | Способ получени гидантоина | |
| BG107065A (bg) | Кристална форма на циталопрам | |
| JP2009537603A (ja) | ５−アミノ−３−（２’，３’−ジ−Ｏ−アセチル−ベータ−Ｄ−リボフラノシル）−３Ｈ−チアゾロ［４，５−ｄ］ピリミジン−２−オンのマレイン酸塩のＡ型及びＢ型結晶形 | |
| RU2011381C1 (ru) | Способ получения кристаллической натриевой соли 5-хлор-3-(2-теноил)-2-оксииндол-1-карбоксамида | |
| JP2022502489A (ja) | αケトグルタル酸カルシウムを製造するためのプロセス | |
| JP2004513106A (ja) | 塩酸ベンラファキシンの結晶形 | |
| JP3140747B2 (ja) | 新規ｉｌ−１阻害剤の合成に有用なフランスルホンアミド化合物の能率的な製造方法 | |
| JP4278652B2 (ja) | 結晶性シブトラミンメタンスルホン酸塩半水和物を含む医薬組成物 | |
| WO2011050638A1 (zh) | 一种比马前列素晶体及其制备方法和用途 | |
| JPS5984822A (ja) | 獣医用鎮痛剤 | |
| CN107033094A (zh) | 一种药物共晶的晶型及其制备方法和组合物 | |
| JP2025502842A5 (https=) | ||
| CN100542525C (zh) | 制备3-羟基-3-甲基丁酸钠固体制剂的方法 | |
| JP2012509930A (ja) | 新規な方法および純粋な多型 | |
| JP3748821B2 (ja) | α−（２−４−ジスルホフェニル）−Ｎ−ｔｅｒｔ−ブチルニトロン及びその医薬上許容しうる塩の新規な製造方法 | |
| JP4177883B2 (ja) | 結晶性ピラゾール誘導体 | |
| TWI354667B (en) | Synthesis of a benzoxazinone | |
| JP2022502487A (ja) | 化合物２，２−ジフルオロ−ｎ−（（１ｒ，２ｓ）−３−フルオロ−１−ヒドロキシ−１−（４−（６−（ｓ−メチルスルホンイミドイル）ピリジン−３−イル）フェニル）プロパン−２−イル）アセトアミドを調製するためのプロセス | |
| BG65428B1 (bg) | Тиазолидиндионово производно, метод за получаването му, фармацевтичен състав и използването му катоантидиабетик | |
| KR100536750B1 (ko) | 시부트라민 메탄술폰산염의 결정성 반수화물을 포함하는약학 조성물 | |
| CN1678584A (zh) | 氨氯地平的有机酸盐 | |
| JPWO2022145420A5 (https=) |